Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective.

Shimizu K, Ogura H, Asahara T, Nomoto K, Morotomi M, Tasaki O, Matsushima A, Kuwagata Y, Shimazu T, Sugimoto H.

Dig Dis Sci. 2013 Jan;58(1):23-32. doi: 10.1007/s10620-012-2334-x. Epub 2012 Aug 19. Review.

2.

Prognostic impact of fecal pH in critically ill patients.

Osuka A, Shimizu K, Ogura H, Tasaki O, Hamasaki T, Asahara T, Nomoto K, Morotomi M, Kuwagata Y, Shimazu T.

Crit Care. 2012 Jul 10;16(4):R119. doi: 10.1186/cc11413.

3.

CO2 -dependent growth of Succinatimonas hippei YIT 12066T isolated from human feces.

Morotomi M, Nagai F, Watanabe Y.

Microbiol Immunol. 2012 Mar;56(3):195-7. doi: 10.1111/j.1348-0421.2012.00420.x.

4.

Characterization of Phascolarctobacterium succinatutens sp. nov., an asaccharolytic, succinate-utilizing bacterium isolated from human feces.

Watanabe Y, Nagai F, Morotomi M.

Appl Environ Microbiol. 2012 Jan;78(2):511-8. doi: 10.1128/AEM.06035-11. Epub 2011 Nov 11.

5.

Description of Christensenella minuta gen. nov., sp. nov., isolated from human faeces, which forms a distinct branch in the order Clostridiales, and proposal of Christensenellaceae fam. nov.

Morotomi M, Nagai F, Watanabe Y.

Int J Syst Evol Microbiol. 2012 Jan;62(Pt 1):144-9. doi: 10.1099/ijs.0.026989-0. Epub 2011 Feb 25.

PMID:
21357455
6.

Gastrointestinal dysmotility is associated with altered gut flora and septic mortality in patients with severe systemic inflammatory response syndrome: a preliminary study.

Shimizu K, Ogura H, Asahara T, Nomoto K, Morotomi M, Nakahori Y, Osuka A, Yamano S, Goto M, Matsushima A, Tasaki O, Kuwagata Y, Sugimoto H.

Neurogastroenterol Motil. 2011 Apr;23(4):330-5, e157. doi: 10.1111/j.1365-2982.2010.01653.x. Epub 2010 Dec 29.

PMID:
21199173
7.

Patterns of Gram-stained fecal flora as a quick diagnostic marker in patients with severe SIRS.

Shimizu K, Ogura H, Tomono K, Tasaki O, Asahara T, Nomoto K, Morotomi M, Matsushima A, Nakahori Y, Yamano S, Osuka A, Kuwagata Y, Sugimoto H.

Dig Dis Sci. 2011 Jun;56(6):1782-8. doi: 10.1007/s10620-010-1486-9. Epub 2010 Nov 24.

8.

Protective effect of Lactobacillus casei strain Shirota against lethal infection with multi-drug resistant Salmonella enterica serovar Typhimurium DT104 in mice.

Asahara T, Shimizu K, Takada T, Kado S, Yuki N, Morotomi M, Tanaka R, Nomoto K.

J Appl Microbiol. 2011 Jan;110(1):163-73. doi: 10.1111/j.1365-2672.2010.04884.x. Epub 2010 Nov 9.

9.

Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome.

Shimizu K, Ogura H, Hamasaki T, Goto M, Tasaki O, Asahara T, Nomoto K, Morotomi M, Matsushima A, Kuwagata Y, Sugimoto H.

Dig Dis Sci. 2011 Apr;56(4):1171-7. doi: 10.1007/s10620-010-1418-8. Epub 2010 Oct 8.

10.

[Altered gut bacterial flora and organic acids in feces of patients undergoing autologous stem cell transplantation with quinolone-based antibacterial prophylaxis].

Hagiwara S, Hagiwara S, Asahara T, Nomoto K, Morotomi M, Ishizuka N, Miwa A, O Yoshida T.

Gan To Kagaku Ryoho. 2010 Jun;37(6):1075-9. Japanese.

PMID:
20567111
11.

Parasutterella secunda sp. nov., isolated from human faeces and proposal of Sutterellaceae fam. nov. in the order Burkholderiales.

Morotomi M, Nagai F, Watanabe Y.

Int J Syst Evol Microbiol. 2011 Mar;61(Pt 3):637-43. doi: 10.1099/ijs.0.023556-0. Epub 2010 Apr 16.

PMID:
20400667
12.

Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele.

Ohishi A, Takahashi S, Ito Y, Ohishi Y, Tsukamoto K, Nanba Y, Ito N, Kakiuchi S, Saitoh A, Morotomi M, Nakamura T.

J Pediatr. 2010 Apr;156(4):679-81. doi: 10.1016/j.jpeds.2009.11.041.

PMID:
20303445
13.

Slackia piriformis sp. nov. and Collinsella tanakaei sp. nov., new members of the family Coriobacteriaceae, isolated from human faeces.

Nagai F, Watanabe Y, Morotomi M.

Int J Syst Evol Microbiol. 2010 Nov;60(Pt 11):2639-46. doi: 10.1099/ijs.0.017533-0. Epub 2009 Dec 18.

PMID:
20023061
14.

Bacteroides clarus sp. nov., Bacteroides fluxus sp. nov. and Bacteroides oleiciplenus sp. nov., isolated from human faeces.

Watanabe Y, Nagai F, Morotomi M, Sakon H, Tanaka R.

Int J Syst Evol Microbiol. 2010 Aug;60(Pt 8):1864-9. doi: 10.1099/ijs.0.015107-0. Epub 2009 Sep 18.

PMID:
19767355
15.

Early use of probiotics is important therapy in infants with severe congenital anomaly.

Kanamori Y, Iwanaka T, Sugiyama M, Komura M, Takahashi T, Yuki N, Morotomi M, Tanaka R.

Pediatr Int. 2010 Jun;52(3):362-7. doi: 10.1111/j.1442-200X.2009.02963.x. Epub 2009 Sep 15.

PMID:
19761515
16.

Succinatimonas hippei gen. nov., sp. nov., isolated from human faeces.

Morotomi M, Nagai F, Watanabe Y, Tanaka R.

Int J Syst Evol Microbiol. 2010 Aug;60(Pt 8):1788-93. doi: 10.1099/ijs.0.015958-0. Epub 2009 Sep 11.

PMID:
19749029
17.

Alistipes indistinctus sp. nov. and Odoribacter laneus sp. nov., common members of the human intestinal microbiota isolated from faeces.

Nagai F, Morotomi M, Watanabe Y, Sakon H, Tanaka R.

Int J Syst Evol Microbiol. 2010 Jun;60(Pt 6):1296-302. doi: 10.1099/ijs.0.014571-0. Epub 2009 Aug 10.

PMID:
19667375
18.

Paraprevotella clara gen. nov., sp. nov. and Paraprevotella xylaniphila sp. nov., members of the family 'Prevotellaceae' isolated from human faeces.

Morotomi M, Nagai F, Sakon H, Tanaka R.

Int J Syst Evol Microbiol. 2009 Aug;59(Pt 8):1895-900. doi: 10.1099/ijs.0.008169-0. Epub 2009 Jun 30.

PMID:
19567577
19.

Parasutterella excrementihominis gen. nov., sp. nov., a member of the family Alcaligenaceae isolated from human faeces.

Nagai F, Morotomi M, Sakon H, Tanaka R.

Int J Syst Evol Microbiol. 2009 Jul;59(Pt 7):1793-7. doi: 10.1099/ijs.0.002519-0. Epub 2009 Jun 19.

PMID:
19542131
20.

Dialister succinatiphilus sp. nov. and Barnesiella intestinihominis sp. nov., isolated from human faeces.

Morotomi M, Nagai F, Sakon H, Tanaka R.

Int J Syst Evol Microbiol. 2008 Dec;58(Pt 12):2716-20. doi: 10.1099/ijs.0.2008/000810-0.

PMID:
19060046
21.

Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse.

Takagi A, Ikemura H, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T.

J Gastroenterol. 2008;43(9):661-9. doi: 10.1007/s00535-008-2212-7. Epub 2008 Sep 20.

PMID:
18807127
22.

Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report.

Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Matsushima A, Tasaki O, Fujita K, Hosotsubo H, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H.

Dig Dis Sci. 2009 May;54(5):1071-8. doi: 10.1007/s10620-008-0460-2. Epub 2008 Aug 23.

PMID:
18726154
23.

Sutterella parvirubra sp. nov. and Megamonas funiformis sp. nov., isolated from human faeces.

Sakon H, Nagai F, Morotomi M, Tanaka R.

Int J Syst Evol Microbiol. 2008 Apr;58(Pt 4):970-5. doi: 10.1099/ijs.0.65456-0.

PMID:
18398204
24.

Genus Megamonas should be placed in the lineage of Firmicutes; Clostridia; Clostridiales; 'Acidaminococcaceae'; Megamonas.

Morotomi M, Nagai F, Sakon H.

Int J Syst Evol Microbiol. 2007 Jul;57(Pt 7):1673-4.

PMID:
17625216
25.

Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome.

Uchida K, Takahashi T, Inoue M, Morotomi M, Otake K, Nakazawa M, Tsukamoto Y, Miki C, Kusunoki M.

Pediatr Surg Int. 2007 Mar;23(3):243-8. Epub 2007 Jan 5.

PMID:
17205292
26.

Altered gut flora and environment in patients with severe SIRS.

Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Yoshiya K, Matsushima A, Sumi Y, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H.

J Trauma. 2006 Jan;60(1):126-33.

PMID:
16456446
27.

Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis.

Kanamori Y, Sugiyama M, Hashizume K, Yuki N, Morotomi M, Tanaka R.

J Pediatr Surg. 2004 Nov;39(11):1686-92.

PMID:
15547835
28.
29.

[Intestinal microflora and cancer prevention].

Morotomi M, Kado S.

Gan To Kagaku Ryoho. 2003 Jun;30(6):741-7. Review. Japanese.

PMID:
12852338
30.

Anaerobic dominant flora was reconstructed by synbiotics in an infant with MRSA enteritis.

Kanamori Y, Hashizume K, Kitano Y, Tanaka Y, Morotomi M, Yuki N, Tanaka R.

Pediatr Int. 2003 Jun;45(3):359-62. No abstract available.

PMID:
12828599
31.

Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms.

Asahara T, Takahashi M, Nomoto K, Takayama H, Onoue M, Morotomi M, Tanaka R, Yokokura T, Yamashita N.

Clin Diagn Lab Immunol. 2003 Jan;10(1):169-73.

32.

Recent trends in functional food science and the industry in Japan.

Arai S, Morinaga Y, Yoshikawa T, Ichiishi E, Kiso Y, Yamazaki M, Morotomi M, Shimizu M, Kuwata T, Kaminogawa S.

Biosci Biotechnol Biochem. 2002 Oct;66(10):2017-29. Review.

33.

Lactobacillus equi sp. nov., a predominant intestinal Lactobacillus species of the horse isolated from faeces of healthy horses.

Morotomi M, Yuki N, Kado Y, Kushiro A, Shimazaki T, Watanabe K, Yuyama T.

Int J Syst Evol Microbiol. 2002 Jan;52(Pt 1):211-4.

PMID:
11837305
34.

Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2.

Takahashi T, Kushiro A, Nomoto K, Uchida K, Morotomi M, Yokokura T, Akaza H.

J Urol. 2001 Dec;166(6):2506-11.

PMID:
11696819
36.

Lactobacillus casei acquires the binding activity to fibronectin by the expression of the fibronectin binding domain of Streptococcus pyogenes on the cell surface.

Kushiro A, Takahashi T, Asahara T, Tsuji H, Nomoto K, Morotomi M.

J Mol Microbiol Biotechnol. 2001 Oct;3(4):563-71.

PMID:
11545275
37.

Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice.

Kado S, Uchida K, Funabashi H, Iwata S, Nagata Y, Ando M, Onoue M, Matsuoka Y, Ohwaki M, Morotomi M.

Cancer Res. 2001 Mar 15;61(6):2395-8.

38.

Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism.

Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T.

Carcinogenesis. 2001 Apr;22(4):599-605.

PMID:
11285195
39.

Colonization of the stratified squamous epithelium of the nonsecreting area of horse stomach by lactobacilli.

Yuki N, Shimazaki T, Kushiro A, Watanabe K, Uchida K, Yuyama T, Morotomi M.

Appl Environ Microbiol. 2000 Nov;66(11):5030-4.

40.

Comparison of the water-holding capacity of wheat bran products prepared by wet and dry smashing methods in vitro and effect on the gastrointestinal retention time in rats in vivo.

Hori T, Matsumoto K, Ikeda M, Moriyama-Ebina R, Sakaitani-Kado Y, Morotomi M.

Int J Vitam Nutr Res. 2000 Jul;70(4):178-84.

PMID:
10989767
41.

The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat.

Yamazaki K, Tsunoda A, Sibusawa M, Tsunoda Y, Kusano M, Fukuchi K, Yamanaka M, Kushima M, Nomoto K, Morotomi M.

Oncol Rep. 2000 Sep-Oct;7(5):977-82.

PMID:
10948325
42.

Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones.

Ohta T, Nakatsugi S, Watanabe K, Kawamori T, Ishikawa F, Morotomi M, Sugie S, Toda T, Sugimura T, Wakabayashi K.

Carcinogenesis. 2000 May;21(5):937-41.

PMID:
10783315
43.

Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice.

Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T.

Med Microbiol Immunol. 1999 Dec;188(3):111-6.

PMID:
10776840
44.

Inhibitory effect of microfibril wheat bran on azoxymethane-induced colon carcinogenesis in CF1 mice.

Takahashi T, Satou M, Watanabe N, Sakaitani Y, Takagi A, Uchida K, Ikeda M, Moriyama R, Matsumoto K, Morotomi M.

Cancer Lett. 1999 Jul 1;141(1-2):139-46. Erratum in: Cancer Lett 1999 Nov 15;146(2):223-4.

PMID:
10454254
45.

Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies.

Yuki N, Watanabe K, Mike A, Tagami Y, Tanaka R, Ohwaki M, Morotomi M.

Int J Food Microbiol. 1999 Apr 1;48(1):51-7.

PMID:
10375134
46.

[Enzyme-linked immunosorbent assay for rapid detection of Clostridium perfringens alpha toxin].

Sakaitani Y, Yuki N, Tagami Y, Morotomi M.

Nihon Saikingaku Zasshi. 1999 Apr;54(2):423-7. Japanese. No abstract available.

PMID:
10356954
47.
48.

Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats.

Onoue M, Kado S, Sakaitani Y, Uchida K, Morotomi M.

Cancer Lett. 1997 Feb 26;113(1-2):179-86.

PMID:
9065820
49.

Effects of a high-fat diet on azoxymethane-induced aberrant crypt foci and fecal biochemistry and microbial activity in rats.

Morotomi M, Sakaitani Y, Satou M, Takahashi T, Takagi A, Onoue M.

Nutr Cancer. 1997;27(1):84-91.

PMID:
8970188
50.

[Production of free bile acids by bacterial deconjugation from conjugated bile acids derived from peptone in a medium].

Morotomi M, Sakaitani Y, Satou M, Takahashi T, Makino T.

Nihon Saikingaku Zasshi. 1996 Oct;51(4):1043-7. Review. Japanese.

PMID:
8994349

Supplemental Content

Loading ...
Support Center